NCT06107361 · ClinicalTrials.gov record · last posted 2026-06-10
Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomized Controlled Trial of Ultrasound-Guided Catheter Survival
StatusRecruiting
PhaseNot applicable
Started2023-11-07
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 10, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
This is a prospective, parallel, non-blinded, two-arm randomized controlled trial of intravenous catheter failure evaluating the impact of a built-in guide wire. The objective of this study is to demonstrate that the control ultralong intravenous catheter (IV) without the guide wire is non-inferior to the experimental catheter with the guide wire. After obtaining consent, eligible patients will be randomly allocated to control Arm 1 (ultralong intravenous catheter) or experimental Arm 2 (ultralong intravenous catheter with guide wire) in a ratio of 1:1 via a computer-generated randomization schedule. The participants will be followed to collect data until the catheter is removed.
Protocol amendment history
2 changes detected by DataLookout
2026-06-11
notable
Primary completion pushed: 2026-03 → 2026-06-30
2026-06-11
minor
Completion pushed: 2026-05 → 2026-07-31
| NCT Number |
NCT06107361 |
| Lead Sponsor |
Corewell Health East
|
| Conditions |
Peripheral Intravenous Vein Catheter Phlebitis, Intravenous Infection |
| Enrollment |
360 participants |
| Start Date |
2023-11-07 |
| Primary Completion |
2026-06-30 (estimated) |
| Study Completion |
2026-07-31 (estimated) |
| Updated on ClinicalTrials.gov |
2026-06-10 |